ALK
ALK-Abello
Stock
Stock
ISIN: DK0061802139
Ticker: ALK B
DK0061802139
ALK B
Price
Price
CHART BY
Historical dividends and forecast
ALK-Abello has so far distributed $0.248 in 2026. The next dividend will be paid on 19.03.2027
$0.0566
CHART BY
Frequently asked questions
What is ALK-Abello's market capitalization?
The market capitalization of ALK-Abello is $7.42B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is ALK-Abello's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for ALK-Abello is 35.03. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for ALK-Abello?
ALK-Abello's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.955. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ALK-Abello's stock?
Currently, 7 analysts cover ALK-Abello's stock, with a consensus target price of $45.64. Analyst ratings provide insights into the stock's expected performance.
What is ALK-Abello's revenue over the trailing twelve months?
Over the trailing twelve months, ALK-Abello reported a revenue of $1.07B.
What is the EBITDA for ALK-Abello?
ALK-Abello's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $339.53M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ALK-Abello?
ALK-Abello has a free cash flow of $295.69M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ALK-Abello have, and what sector and industry does it belong to?
ALK-Abello employs approximately 2,721 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of ALK-Abello's shares?
The free float of ALK-Abello is 121.13M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $7.42B
- EPS (TTM)
- $0.955
- Free Float
- 121.13M
- P/E ratio (TTM)
- 35.03
- Revenue (TTM)
- $1.07B
- EBITDA (TTM)
- $339.53M
- Free Cashflow (TTM)
- $295.69M
Pricing
- 1D span
- $33.11$33.95
- 52W span
- $29.89$42.15
Analyst Ratings
The price target is $45.64 and the stock is covered by 7 analysts.
Buy
6
Hold
1
Sell
0
Information
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. The firm manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.
- Employees
- 2,721
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- DK0061802139
- Primary Ticker
- ALK B
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet